Interventional Oncology Solutions Market - Size,
Share, Outlook, and Opportunity Analysis, 2018 –
2026
Interventional oncology is a field of medical science, which includes treatment and diagnosis of
cancer and other problems related to cancer using minimally invasive procedures. Interventional
oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and
magnetic resonance imaging (MRI) to treat tumors located in various organs of the body.
Interventional oncology procedures are usually used to treat metastatic or primary cancer. These
procedures can be used to treat cancer in pancreas, liver, lung, breast, prostrate, kidney, and
bones. Interventional oncology procedures are segmented into two procedures i.e. diagnostic and
therapeutic. Therapeutic procedures can be further categorized into ablation techniques and
embolization techniques. Ablation techniques uses some form of heat to destroy tumor.
Embolization Technique occludes blood vessels, which feed tumors and further destroy the
tumor by means of ischemia. Both these procedures are minimally invasive and there is
minimal pain, complications, and discomfort with rapid recovery.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/1884
Interventional Oncology Solutions Market Drivers:-
Increasing popularity of minimal invasive procedures due to advantages such as minimal risk of
infection, shorter stay in the hospitals, minimal complications, minimal pain, and faster
recovery as compared to invasive surgeries, is a major factor supporting the global
interventional oncology solutions market growth over the forecast period. Moreover, increasing
product launches is expected to aid in growth in interventional oncology solutions market size.
For instance, in 2017, Terumo Corporation, a Japan-based company, launched Quirem Spheres
microspheres. This is used to treat solid liver tumors, which cannot be removed by surgery
completely. Microspheres consists of a radioactive isotope Holium-166. Quirem Spheres and can
also be visualized in low concentrations by means of SPECT (Single Photon Emission Computed
Tomography) and MRI. This feature allows doctors to carefully assess distribution of
microspheres in the organs such as liver, which enables in accurate assessment of treatment
after SIRT (Selective Internal radiation Therapy) procedure. Half-life of Quirem Spheres is 26.8